Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Baxalta Incorporated (NYSE: BXLT) acted responsibly on behalf of investors’ profitability in the planned $32 billion sale to Shire plc (NASDAQ: SHPG).

On January 11, 2016, Baxalta Incorporated (NYSE: BXLT) and Shire plc (NASDAQ: SHPG) announced that they had entered into a merger agreement. Under the terms of the agreement, Baxalta shareholders will receive $18.00 in cash and 0.1482 Shire ADS per Baxalta share.

Based in Deerfield, Illinois and founded in 2014 Baxalta Incorporated is a biopharmaceutical company, engaged in developing, and manufacturing a portfolio of products primarily for the treatment of hematology and immunology.

The investigation is looking to uncover whether Baxalta Incorporated was undervalued at the cost of the shareholders considering one analyst’s opinion of their stock is valued at $47.00 per share.

If you purchased Baxalta Incorporated (NYSE: BXLT) prior to January 11, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185